IL10 and stroke disorder: Increased β2-adrenergic signaling after an experimental stroke typically inhibits microglial/monocyte-derived macrophage response and reduces the upregulation of pro-inflammatory and anti-inflammatory cytokines (TNFα and IL-10) (169).